Yongxiang Jiang

Dr. Yongxiang Jiang

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2021 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
ZCZexu Chen
Zexu Chen
MZMin Zhang
Min Zhang
MDMichael Deng
Michael Deng
TCTianhui Chen
Tianhui Chen
JCJiahui Chen
Jiahui Chen
YJYongxiang Jiang
Yongxiang Jiang
To evaluate surgical outcomes of modified capsular tension ring (MCTR) and intraocular lens (IOL) implantation in eyes of Marfan syndrome (MFS). This retrospective case series included MFS patients receiving MCTR transscleral fixation and IOL in-the-bag implantation. The MCTR was sutured to the sclera through a sulcus by 9–0 polypropylene with the modified knotless Z-suture technique. Main outcomes were visual acuity and postoperative complications. A total of 109 MFS patients (187 eyes) had the surgery. Patients were 15.47 ± 14.36 years old and followed up for 10.07 ± 8.99 months. MCTR and IOL implantations were performed in 174 eyes (93.05%). The postoperative BCVA (LogMAR) was 0.24 ± 0.24 (1 month), 0.26 ± 0.20 (3 months), 0.22 ± 0.20 (6 months), 0.20 ± 0.19 (12 months) and 0.25 ± 0.32 (over 12 months), which was significantly better than preoperatively (0.63 ± 0.35) (p < 0.001). Major complications included posterior capsular opacification (PCO) in 41 eyes (23.56%) and decentered anterior capsular opacification (ACO) in 15 eyes (8.62%). The mean occurrence time was 9.44 ± 7.08 and 8.87 ± 15.08 months respectively. Other complications included transient intraocular pressure elevation in seven eyes (4.02%), retinal detachment in two eyes (1.15%), cystoid macula edema in one eye (0.57%), and endophthalmitis in one eye (0.57%). No eye had suture breakage or IOL dislocation. The visual improvement is significant in eyes of MFS undergoing MCTR transscleral fixation and IOL in-the-bag implantation. The long-term monitoring of complications is warranted, especially in the first-two years.

22 September 2021 in Human Mutation
Verified
Journal Article
Closed access
PDF file
ZCZe‐Xu Chen
Ze‐Xu Chen
TCTian‐Hui Chen
Tian‐Hui Chen
MZMin Zhang
Min Zhang
JCJia‐Hui Chen
Jia‐Hui Chen
LLLi‐Na Lan
Li‐Na Lan
YJYongxiang Jiang
Yongxiang Jiang

16 August 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
ZCZe-Xu Chen
Ze-Xu Chen
WJWan-Nan Jia
Wan-Nan Jia
YJYongxiang Jiang
Yongxiang Jiang
Marfan syndrome (MFS, OMIM: 154700) is a heritable multisystemic disease characterized by a wide range of clinical manifestations. The underlying molecular defect is caused by variants in the FBN1. Meanwhile, FBN1 variants are also detected in a spectrum of connective tissue disorders collectively termed as ‘type I fibrillinopathies’. A multitude of FBN1 variants is reported and most of them are unique in each pedigree. Although MFS is being considered a monogenic disorder, it is speculated that the allelic heterogeneity of FBN1 variants contributes to various manifestations, distinct prognoses, and differential responses to the therapies in affected patients. Significant progress in the genotype–phenotype correlations of MFS have emerged in the last 20 years, though, some of the associations were still in debate. This review aims to update the recent advances in the genotype-phenotype correlations of MFS and related fibrillinopathies. The molecular bases and pathological mechanisms are summarized for better support of the observed correlations. Other factors contributing to the phenotype heterogeneity and future research directions were also discussed. Dissecting the genotype-phenotype correlation of FBN1 variants and related disorders will provide valuable information in risk stratification, prognosis, and choice of therapy.

1 May 2022 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
TCTian-Hui Chen
Tian-Hui Chen
ZCZe-Xu Chen
Ze-Xu Chen
MZMin Zhang
Min Zhang
JCJia-Hui Chen
Jia-Hui Chen
MDMichael Deng
Michael Deng
YJYongxiang Jiang
Yongxiang Jiang

1 October 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YSYang Sun
Yang Sun
XRXianfang Rong
Xianfang Rong
DLDan Li
Dan Li
YJYongxiang Jiang
Yongxiang Jiang
YLYi Lu
Yi Lu
YJYinghong Ji
Yinghong Ji

4 February 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TCTianhui Chen
Tianhui Chen
MDMichael Deng
Michael Deng
MZMin Zhang
Min Zhang
JCJiahui Chen
Jiahui Chen
ZCZexu Chen
Zexu Chen
YJYongxiang Jiang
Yongxiang Jiang
Marfan syndrome (MFS) is a hereditary disease with an incidence of 0.3% in the general population. Approximately 60% of MFS patients with FBN1 gene mutation will suffer ectopia lentis (EL) from the age of 3. With the development of EL, severe loss of vision will accrue because of lens tilt and glaucoma. Cionni modified capsular tension rings (MCTR) has been applied in the surgery for EL in MFS patients. To evaluate visual acuity and safety of using MCTR during lens subluxation surgery in MFS patients, 66 MFS patients (110 eyes) were included in our study, with the mean duration of follow-up of 4.7 months (SD 1.76 months). The capsular bags were preserved in 101 eyes (91.81%) with MCTR implantation. There was an overall significant improvement in BCVA at 1-month follow-up which was maintained at 3 months. Multivariable linear regression revealed that older age at first visit was associated with greater postoperative BCVA at the 1-month follow-up (P = 0.007). A significant difference was found between different degrees of lens subluxation and the length of surgical time and complications. At follow-up, only two eyes (1.98%) were identified to have developed retinal detachments. In conclusion, better visual outcomes can be achieved when patients received an early operation with MCTR implantation.